Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Minoxidil in HA-PLGA nanoparticles effectively treats alopecia through skin delivery.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Certain herbal combinations in traditional Chinese medicine might be effective for treating hair loss, focusing on liver or stomach health.

A portable device can create nanofibers to improve the appearance of thinning hair better than commercial products.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

People undergoing chemotherapy need better support and information to cope with hair loss.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.